Postmarketing Clinical Study on AO-128
NCT02287402
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
197
Enrollment
INDUSTRY
Sponsor class
Conditions
Impaired Glucose Tolerance (IGT)
Interventions
DRUG:
AO-128
Sponsor
Takeda